nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP3A4—Everolimus—kidney cancer	0.14	0.185	CbGbCtD
Ramelteon—CYP1A2—Pazopanib—kidney cancer	0.0946	0.126	CbGbCtD
Ramelteon—CYP3A4—Temsirolimus—kidney cancer	0.0943	0.125	CbGbCtD
Ramelteon—CYP1A2—Erlotinib—kidney cancer	0.0675	0.0896	CbGbCtD
Ramelteon—CYP2C19—Sorafenib—kidney cancer	0.0595	0.0789	CbGbCtD
Ramelteon—CYP1A2—Sorafenib—kidney cancer	0.0549	0.0728	CbGbCtD
Ramelteon—CYP3A4—Pazopanib—kidney cancer	0.0495	0.0658	CbGbCtD
Ramelteon—CYP3A4—Erlotinib—kidney cancer	0.0354	0.0469	CbGbCtD
Ramelteon—CYP3A4—Paclitaxel—kidney cancer	0.0324	0.043	CbGbCtD
Ramelteon—CYP3A4—Sorafenib—kidney cancer	0.0287	0.0382	CbGbCtD
Ramelteon—CYP3A4—Vinblastine—kidney cancer	0.0284	0.0377	CbGbCtD
Ramelteon—CYP3A4—Vincristine—kidney cancer	0.0279	0.037	CbGbCtD
Ramelteon—CYP3A4—Sunitinib—kidney cancer	0.0233	0.0309	CbGbCtD
Ramelteon—CYP3A4—Doxorubicin—kidney cancer	0.0174	0.0232	CbGbCtD
Ramelteon—Influenza—Temsirolimus—kidney cancer	0.00335	0.0187	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Temsirolimus—kidney cancer	0.00311	0.0174	CcSEcCtD
Ramelteon—Depression—Temsirolimus—kidney cancer	0.00298	0.0166	CcSEcCtD
Ramelteon—Influenza—Everolimus—kidney cancer	0.00249	0.0139	CcSEcCtD
Ramelteon—Thinking abnormal—Paclitaxel—kidney cancer	0.00243	0.0136	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Everolimus—kidney cancer	0.00231	0.0129	CcSEcCtD
Ramelteon—Dysgeusia—Temsirolimus—kidney cancer	0.00228	0.0128	CcSEcCtD
Ramelteon—Depression—Vinblastine—kidney cancer	0.00222	0.0124	CcSEcCtD
Ramelteon—Dysgeusia—Pazopanib—kidney cancer	0.00215	0.012	CcSEcCtD
Ramelteon—Depression—Erlotinib—kidney cancer	0.00214	0.0119	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Gemcitabine—kidney cancer	0.002	0.0112	CcSEcCtD
Ramelteon—Arthralgia—Temsirolimus—kidney cancer	0.00199	0.0111	CcSEcCtD
Ramelteon—Myalgia—Temsirolimus—kidney cancer	0.00199	0.0111	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Sunitinib—kidney cancer	0.00193	0.0108	CcSEcCtD
Ramelteon—Mental disability—Paclitaxel—kidney cancer	0.00193	0.0108	CcSEcCtD
Ramelteon—Anaphylactic shock—Temsirolimus—kidney cancer	0.0019	0.0106	CcSEcCtD
Ramelteon—Arthralgia—Pazopanib—kidney cancer	0.00187	0.0105	CcSEcCtD
Ramelteon—Myalgia—Pazopanib—kidney cancer	0.00187	0.0105	CcSEcCtD
Ramelteon—Depression—Sunitinib—kidney cancer	0.00185	0.0103	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Temsirolimus—kidney cancer	0.00173	0.00969	CcSEcCtD
Ramelteon—Insomnia—Temsirolimus—kidney cancer	0.00172	0.00962	CcSEcCtD
Ramelteon—Dysgeusia—Everolimus—kidney cancer	0.0017	0.0095	CcSEcCtD
Ramelteon—Somnolence—Temsirolimus—kidney cancer	0.00169	0.00946	CcSEcCtD
Ramelteon—Influenza—Gemcitabine—kidney cancer	0.00167	0.00933	CcSEcCtD
Ramelteon—Fatigue—Temsirolimus—kidney cancer	0.00164	0.00917	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.00163	0.00913	CcSEcCtD
Ramelteon—Insomnia—Pazopanib—kidney cancer	0.00162	0.00907	CcSEcCtD
Ramelteon—Somnolence—Pazopanib—kidney cancer	0.00159	0.00891	CcSEcCtD
Ramelteon—Mental disability—Capecitabine—kidney cancer	0.00159	0.00886	CcSEcCtD
Ramelteon—Depression—Vincristine—kidney cancer	0.00156	0.00874	CcSEcCtD
Ramelteon—Fatigue—Pazopanib—kidney cancer	0.00155	0.00864	CcSEcCtD
Ramelteon—Myalgia—Everolimus—kidney cancer	0.00148	0.00826	CcSEcCtD
Ramelteon—Arthralgia—Everolimus—kidney cancer	0.00148	0.00826	CcSEcCtD
Ramelteon—Dysgeusia—Sorafenib—kidney cancer	0.00148	0.00824	CcSEcCtD
Ramelteon—Arthralgia—Erlotinib—kidney cancer	0.00143	0.00797	CcSEcCtD
Ramelteon—Myalgia—Erlotinib—kidney cancer	0.00143	0.00797	CcSEcCtD
Ramelteon—Dysgeusia—Sunitinib—kidney cancer	0.00142	0.00793	CcSEcCtD
Ramelteon—Influenza—Paclitaxel—kidney cancer	0.0014	0.00781	CcSEcCtD
Ramelteon—Asthenia—Temsirolimus—kidney cancer	0.00137	0.00763	CcSEcCtD
Ramelteon—Diarrhoea—Temsirolimus—kidney cancer	0.0013	0.00728	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.0013	0.00726	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00129	0.00721	CcSEcCtD
Ramelteon—Thinking abnormal—Doxorubicin—kidney cancer	0.00129	0.00719	CcSEcCtD
Ramelteon—Asthenia—Pazopanib—kidney cancer	0.00129	0.00719	CcSEcCtD
Ramelteon—Arthralgia—Sorafenib—kidney cancer	0.00128	0.00717	CcSEcCtD
Ramelteon—Myalgia—Sorafenib—kidney cancer	0.00128	0.00717	CcSEcCtD
Ramelteon—Insomnia—Everolimus—kidney cancer	0.00128	0.00716	CcSEcCtD
Ramelteon—Somnolence—Everolimus—kidney cancer	0.00126	0.00704	CcSEcCtD
Ramelteon—Dizziness—Temsirolimus—kidney cancer	0.00126	0.00704	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00125	0.00696	CcSEcCtD
Ramelteon—Depression—Paclitaxel—kidney cancer	0.00124	0.00694	CcSEcCtD
Ramelteon—Insomnia—Erlotinib—kidney cancer	0.00124	0.00691	CcSEcCtD
Ramelteon—Arthralgia—Sunitinib—kidney cancer	0.00123	0.0069	CcSEcCtD
Ramelteon—Myalgia—Sunitinib—kidney cancer	0.00123	0.0069	CcSEcCtD
Ramelteon—Anaphylactic shock—Sorafenib—kidney cancer	0.00123	0.00687	CcSEcCtD
Ramelteon—Diarrhoea—Pazopanib—kidney cancer	0.00123	0.00686	CcSEcCtD
Ramelteon—Fatigue—Everolimus—kidney cancer	0.00122	0.00682	CcSEcCtD
Ramelteon—Headache—Temsirolimus—kidney cancer	0.00119	0.00667	CcSEcCtD
Ramelteon—Dizziness—Pazopanib—kidney cancer	0.00119	0.00663	CcSEcCtD
Ramelteon—Fatigue—Erlotinib—kidney cancer	0.00118	0.00658	CcSEcCtD
Ramelteon—Myalgia—Dactinomycin—kidney cancer	0.00117	0.00653	CcSEcCtD
Ramelteon—Influenza—Capecitabine—kidney cancer	0.00115	0.00641	CcSEcCtD
Ramelteon—Nausea—Temsirolimus—kidney cancer	0.00113	0.00632	CcSEcCtD
Ramelteon—Headache—Pazopanib—kidney cancer	0.00112	0.00628	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00112	0.00626	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00108	0.00602	CcSEcCtD
Ramelteon—Insomnia—Sunitinib—kidney cancer	0.00107	0.00598	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Capecitabine—kidney cancer	0.00107	0.00596	CcSEcCtD
Ramelteon—Nausea—Pazopanib—kidney cancer	0.00107	0.00595	CcSEcCtD
Ramelteon—Fatigue—Sorafenib—kidney cancer	0.00106	0.00592	CcSEcCtD
Ramelteon—Myalgia—Vincristine—kidney cancer	0.00104	0.00583	CcSEcCtD
Ramelteon—Mental disability—Doxorubicin—kidney cancer	0.00102	0.00571	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00102	0.0057	CcSEcCtD
Ramelteon—Asthenia—Vinblastine—kidney cancer	0.00102	0.0057	CcSEcCtD
Ramelteon—Fatigue—Sunitinib—kidney cancer	0.00102	0.0057	CcSEcCtD
Ramelteon—Depression—Capecitabine—kidney cancer	0.00102	0.0057	CcSEcCtD
Ramelteon—Asthenia—Everolimus—kidney cancer	0.00102	0.00568	CcSEcCtD
Ramelteon—Anaphylactic shock—Vincristine—kidney cancer	0.001	0.00559	CcSEcCtD
Ramelteon—Arthralgia—Gemcitabine—kidney cancer	0.00099	0.00553	CcSEcCtD
Ramelteon—Myalgia—Gemcitabine—kidney cancer	0.00099	0.00553	CcSEcCtD
Ramelteon—Asthenia—Erlotinib—kidney cancer	0.000981	0.00548	CcSEcCtD
Ramelteon—Diarrhoea—Vinblastine—kidney cancer	0.000973	0.00544	CcSEcCtD
Ramelteon—Diarrhoea—Everolimus—kidney cancer	0.000969	0.00541	CcSEcCtD
Ramelteon—Fatigue—Dactinomycin—kidney cancer	0.000966	0.0054	CcSEcCtD
Ramelteon—Dysgeusia—Paclitaxel—kidney cancer	0.000954	0.00533	CcSEcCtD
Ramelteon—Anaphylactic shock—Gemcitabine—kidney cancer	0.000949	0.0053	CcSEcCtD
Ramelteon—Dizziness—Vinblastine—kidney cancer	0.00094	0.00525	CcSEcCtD
Ramelteon—Dizziness—Everolimus—kidney cancer	0.000937	0.00523	CcSEcCtD
Ramelteon—Diarrhoea—Erlotinib—kidney cancer	0.000935	0.00522	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000912	0.00509	CcSEcCtD
Ramelteon—Insomnia—Vincristine—kidney cancer	0.000905	0.00506	CcSEcCtD
Ramelteon—Dizziness—Erlotinib—kidney cancer	0.000904	0.00505	CcSEcCtD
Ramelteon—Headache—Vinblastine—kidney cancer	0.000891	0.00498	CcSEcCtD
Ramelteon—Headache—Everolimus—kidney cancer	0.000887	0.00496	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000884	0.00494	CcSEcCtD
Ramelteon—Asthenia—Sorafenib—kidney cancer	0.000882	0.00493	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000865	0.00483	CcSEcCtD
Ramelteon—Fatigue—Vincristine—kidney cancer	0.000863	0.00482	CcSEcCtD
Ramelteon—Insomnia—Gemcitabine—kidney cancer	0.000859	0.0048	CcSEcCtD
Ramelteon—Headache—Erlotinib—kidney cancer	0.000856	0.00478	CcSEcCtD
Ramelteon—Asthenia—Sunitinib—kidney cancer	0.000849	0.00474	CcSEcCtD
Ramelteon—Nausea—Vinblastine—kidney cancer	0.000845	0.00472	CcSEcCtD
Ramelteon—Somnolence—Gemcitabine—kidney cancer	0.000844	0.00472	CcSEcCtD
Ramelteon—Nausea—Everolimus—kidney cancer	0.000841	0.0047	CcSEcCtD
Ramelteon—Diarrhoea—Sorafenib—kidney cancer	0.000841	0.0047	CcSEcCtD
Ramelteon—Arthralgia—Paclitaxel—kidney cancer	0.000829	0.00463	CcSEcCtD
Ramelteon—Myalgia—Paclitaxel—kidney cancer	0.000829	0.00463	CcSEcCtD
Ramelteon—Fatigue—Gemcitabine—kidney cancer	0.000818	0.00457	CcSEcCtD
Ramelteon—Dizziness—Sorafenib—kidney cancer	0.000813	0.00454	CcSEcCtD
Ramelteon—Nausea—Erlotinib—kidney cancer	0.000812	0.00454	CcSEcCtD
Ramelteon—Diarrhoea—Sunitinib—kidney cancer	0.000809	0.00452	CcSEcCtD
Ramelteon—Asthenia—Dactinomycin—kidney cancer	0.000804	0.00449	CcSEcCtD
Ramelteon—Anaphylactic shock—Paclitaxel—kidney cancer	0.000795	0.00444	CcSEcCtD
Ramelteon—Dysgeusia—Capecitabine—kidney cancer	0.000783	0.00437	CcSEcCtD
Ramelteon—Dizziness—Sunitinib—kidney cancer	0.000782	0.00437	CcSEcCtD
Ramelteon—Headache—Sorafenib—kidney cancer	0.00077	0.0043	CcSEcCtD
Ramelteon—Diarrhoea—Dactinomycin—kidney cancer	0.000766	0.00428	CcSEcCtD
Ramelteon—Headache—Sunitinib—kidney cancer	0.000741	0.00414	CcSEcCtD
Ramelteon—Influenza—Doxorubicin—kidney cancer	0.000739	0.00413	CcSEcCtD
Ramelteon—Nausea—Sorafenib—kidney cancer	0.00073	0.00408	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000724	0.00405	CcSEcCtD
Ramelteon—Insomnia—Paclitaxel—kidney cancer	0.000719	0.00402	CcSEcCtD
Ramelteon—Asthenia—Vincristine—kidney cancer	0.000718	0.00401	CcSEcCtD
Ramelteon—Somnolence—Paclitaxel—kidney cancer	0.000707	0.00395	CcSEcCtD
Ramelteon—Nausea—Sunitinib—kidney cancer	0.000703	0.00393	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000687	0.00384	CcSEcCtD
Ramelteon—Fatigue—Paclitaxel—kidney cancer	0.000685	0.00383	CcSEcCtD
Ramelteon—Diarrhoea—Vincristine—kidney cancer	0.000685	0.00383	CcSEcCtD
Ramelteon—Asthenia—Gemcitabine—kidney cancer	0.000681	0.00381	CcSEcCtD
Ramelteon—Myalgia—Capecitabine—kidney cancer	0.00068	0.0038	CcSEcCtD
Ramelteon—Arthralgia—Capecitabine—kidney cancer	0.00068	0.0038	CcSEcCtD
Ramelteon—Nausea—Dactinomycin—kidney cancer	0.000665	0.00372	CcSEcCtD
Ramelteon—Dizziness—Vincristine—kidney cancer	0.000662	0.0037	CcSEcCtD
Ramelteon—Diarrhoea—Gemcitabine—kidney cancer	0.000649	0.00363	CcSEcCtD
Ramelteon—Headache—Vincristine—kidney cancer	0.000627	0.0035	CcSEcCtD
Ramelteon—Headache—Gemcitabine—kidney cancer	0.000595	0.00332	CcSEcCtD
Ramelteon—Nausea—Vincristine—kidney cancer	0.000594	0.00332	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000594	0.00332	CcSEcCtD
Ramelteon—Insomnia—Capecitabine—kidney cancer	0.00059	0.0033	CcSEcCtD
Ramelteon—Asthenia—Paclitaxel—kidney cancer	0.00057	0.00319	CcSEcCtD
Ramelteon—Nausea—Gemcitabine—kidney cancer	0.000564	0.00315	CcSEcCtD
Ramelteon—Fatigue—Capecitabine—kidney cancer	0.000562	0.00314	CcSEcCtD
Ramelteon—Diarrhoea—Paclitaxel—kidney cancer	0.000544	0.00304	CcSEcCtD
Ramelteon—Dizziness—Paclitaxel—kidney cancer	0.000526	0.00294	CcSEcCtD
Ramelteon—Dysgeusia—Doxorubicin—kidney cancer	0.000504	0.00282	CcSEcCtD
Ramelteon—Headache—Paclitaxel—kidney cancer	0.000498	0.00278	CcSEcCtD
Ramelteon—Nausea—Paclitaxel—kidney cancer	0.000472	0.00264	CcSEcCtD
Ramelteon—Asthenia—Capecitabine—kidney cancer	0.000468	0.00261	CcSEcCtD
Ramelteon—Diarrhoea—Capecitabine—kidney cancer	0.000446	0.00249	CcSEcCtD
Ramelteon—Myalgia—Doxorubicin—kidney cancer	0.000439	0.00245	CcSEcCtD
Ramelteon—Arthralgia—Doxorubicin—kidney cancer	0.000439	0.00245	CcSEcCtD
Ramelteon—Dizziness—Capecitabine—kidney cancer	0.000431	0.00241	CcSEcCtD
Ramelteon—Anaphylactic shock—Doxorubicin—kidney cancer	0.00042	0.00235	CcSEcCtD
Ramelteon—Headache—Capecitabine—kidney cancer	0.000409	0.00228	CcSEcCtD
Ramelteon—Nausea—Capecitabine—kidney cancer	0.000387	0.00216	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000383	0.00214	CcSEcCtD
Ramelteon—Insomnia—Doxorubicin—kidney cancer	0.00038	0.00212	CcSEcCtD
Ramelteon—Somnolence—Doxorubicin—kidney cancer	0.000374	0.00209	CcSEcCtD
Ramelteon—Fatigue—Doxorubicin—kidney cancer	0.000362	0.00203	CcSEcCtD
Ramelteon—Asthenia—Doxorubicin—kidney cancer	0.000302	0.00169	CcSEcCtD
Ramelteon—Diarrhoea—Doxorubicin—kidney cancer	0.000288	0.00161	CcSEcCtD
Ramelteon—Dizziness—Doxorubicin—kidney cancer	0.000278	0.00155	CcSEcCtD
Ramelteon—Headache—Doxorubicin—kidney cancer	0.000263	0.00147	CcSEcCtD
Ramelteon—Nausea—Doxorubicin—kidney cancer	0.00025	0.0014	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—FLT1—kidney cancer	0.00012	0.00177	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—FLT1—kidney cancer	0.00012	0.00177	CbGpPWpGaD
Ramelteon—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	0.000116	0.00172	CbGpPWpGaD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000116	0.00172	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000116	0.00171	CbGpPWpGaD
Ramelteon—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000114	0.00169	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.000114	0.00168	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.000113	0.00168	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000113	0.00168	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—POMC—kidney cancer	0.000113	0.00167	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—POMC—kidney cancer	0.000113	0.00167	CbGpPWpGaD
Ramelteon—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000112	0.00165	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—JUNB—kidney cancer	0.000111	0.00164	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—JUNB—kidney cancer	0.000111	0.00164	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PAK1—kidney cancer	0.000111	0.00164	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PAK1—kidney cancer	0.000111	0.00164	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	0.00011	0.00163	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTT1—kidney cancer	0.000107	0.00158	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	0.000104	0.00154	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	0.000104	0.00154	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000103	0.00152	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—POMC—kidney cancer	0.000102	0.00152	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—POMC—kidney cancer	0.000102	0.00152	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	0.000102	0.00151	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—PTGS1—kidney cancer	0.0001	0.00148	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	9.93e-05	0.00147	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTP1—kidney cancer	9.5e-05	0.0014	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	9.37e-05	0.00139	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	9.37e-05	0.00139	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IGF2—kidney cancer	9.07e-05	0.00134	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IGF2—kidney cancer	9.07e-05	0.00134	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	9.05e-05	0.00134	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CDKN2B—kidney cancer	9.03e-05	0.00134	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CDKN2B—kidney cancer	9.03e-05	0.00134	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.83e-05	0.00131	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IGF1R—kidney cancer	8.77e-05	0.0013	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IGF1R—kidney cancer	8.77e-05	0.0013	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTM1—kidney cancer	8.73e-05	0.00129	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	8.68e-05	0.00128	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	8.62e-05	0.00127	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	8.61e-05	0.00127	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—RAF1—kidney cancer	8.45e-05	0.00125	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—RAF1—kidney cancer	8.45e-05	0.00125	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—IL2—kidney cancer	8.34e-05	0.00123	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—IL2—kidney cancer	8.34e-05	0.00123	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	8.28e-05	0.00122	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTT1—kidney cancer	8.24e-05	0.00122	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	8.16e-05	0.00121	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	7.98e-05	0.00118	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	7.81e-05	0.00115	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—PTGS1—kidney cancer	7.72e-05	0.00114	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL2—kidney cancer	7.58e-05	0.00112	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL2—kidney cancer	7.58e-05	0.00112	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTP1—kidney cancer	7.4e-05	0.00109	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	7.38e-05	0.00109	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	7.3e-05	0.00108	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ACY1—kidney cancer	7.28e-05	0.00108	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HIF1A—kidney cancer	7.22e-05	0.00107	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HIF1A—kidney cancer	7.22e-05	0.00107	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TSC2—kidney cancer	7.2e-05	0.00106	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TSC2—kidney cancer	7.2e-05	0.00106	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.99e-05	0.00103	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—KDR—kidney cancer	6.9e-05	0.00102	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KDR—kidney cancer	6.9e-05	0.00102	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTM1—kidney cancer	6.8e-05	0.00101	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	6.71e-05	0.000992	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	6.45e-05	0.000954	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	6.36e-05	0.000941	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—APC—kidney cancer	6.36e-05	0.00094	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—APC—kidney cancer	6.36e-05	0.00094	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—KIT—kidney cancer	6.36e-05	0.00094	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KIT—kidney cancer	6.36e-05	0.00094	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.21e-05	0.000918	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PDHB—kidney cancer	6.19e-05	0.000915	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—POMC—kidney cancer	6.17e-05	0.000913	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—MAPK3—kidney cancer	6.09e-05	0.000901	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—MAPK3—kidney cancer	6.09e-05	0.000901	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—POMC—kidney cancer	6.05e-05	0.000895	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—POMC—kidney cancer	6.05e-05	0.000895	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—BRAF—kidney cancer	5.98e-05	0.000884	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—BRAF—kidney cancer	5.98e-05	0.000884	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CCBL1—kidney cancer	5.82e-05	0.000861	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—MAPK1—kidney cancer	5.79e-05	0.000857	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—MAPK1—kidney cancer	5.79e-05	0.000857	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTP1—kidney cancer	5.71e-05	0.000845	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ACY1—kidney cancer	5.67e-05	0.000839	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	5.63e-05	0.000833	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PIK3CA—kidney cancer	5.54e-05	0.000819	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—PIK3CA—kidney cancer	5.54e-05	0.000819	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—KRAS—kidney cancer	5.47e-05	0.000809	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—KRAS—kidney cancer	5.47e-05	0.000809	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.26e-05	0.000778	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTM1—kidney cancer	5.25e-05	0.000776	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	5.18e-05	0.000766	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GLIPR1—kidney cancer	5.05e-05	0.000746	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PPAT—kidney cancer	5.05e-05	0.000746	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PIK3CA—kidney cancer	5.03e-05	0.000744	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PIK3CA—kidney cancer	5.03e-05	0.000744	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—RAF1—kidney cancer	4.99e-05	0.000738	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—RAF1—kidney cancer	4.99e-05	0.000738	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.98e-05	0.000737	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	4.98e-05	0.000736	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—RELA—kidney cancer	4.97e-05	0.000735	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—RELA—kidney cancer	4.97e-05	0.000735	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ERBB2—kidney cancer	4.94e-05	0.00073	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ERBB2—kidney cancer	4.94e-05	0.00073	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.93e-05	0.000729	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	4.91e-05	0.000726	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MTOR—kidney cancer	4.87e-05	0.000721	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MTOR—kidney cancer	4.87e-05	0.000721	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.84e-05	0.000715	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PDHB—kidney cancer	4.82e-05	0.000713	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—POMC—kidney cancer	4.81e-05	0.000711	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—FH—kidney cancer	4.69e-05	0.000694	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—APRT—kidney cancer	4.69e-05	0.000694	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.59e-05	0.000678	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CDKN1B—kidney cancer	4.57e-05	0.000676	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CDKN1B—kidney cancer	4.57e-05	0.000676	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CCBL1—kidney cancer	4.53e-05	0.000671	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL2—kidney cancer	4.48e-05	0.000662	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL2—kidney cancer	4.48e-05	0.000662	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GPC3—kidney cancer	4.41e-05	0.000652	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ACY1—kidney cancer	4.38e-05	0.000647	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCND1—kidney cancer	4.36e-05	0.000645	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCND1—kidney cancer	4.36e-05	0.000645	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—JUN—kidney cancer	4.35e-05	0.000644	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—JUN—kidney cancer	4.35e-05	0.000644	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CTNNB1—kidney cancer	4.32e-05	0.000639	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CTNNB1—kidney cancer	4.32e-05	0.000639	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CA2—kidney cancer	4.29e-05	0.000634	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTEN—kidney cancer	4.21e-05	0.000623	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTEN—kidney cancer	4.21e-05	0.000623	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ALAD—kidney cancer	4.18e-05	0.000618	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.1e-05	0.000606	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ST3GAL2—kidney cancer	4.08e-05	0.000604	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ALDH1A1—kidney cancer	3.99e-05	0.00059	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GLIPR1—kidney cancer	3.93e-05	0.000581	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PPAT—kidney cancer	3.93e-05	0.000581	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.88e-05	0.000574	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.84e-05	0.000568	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PGK1—kidney cancer	3.82e-05	0.000566	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC5A3—kidney cancer	3.82e-05	0.000566	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—VEGFA—kidney cancer	3.8e-05	0.000562	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—VEGFA—kidney cancer	3.8e-05	0.000562	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—LDHB—kidney cancer	3.75e-05	0.000555	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PDHB—kidney cancer	3.72e-05	0.00055	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—POMC—kidney cancer	3.71e-05	0.000549	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—APRT—kidney cancer	3.66e-05	0.000541	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—FH—kidney cancer	3.66e-05	0.000541	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MAPK3—kidney cancer	3.6e-05	0.000532	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MAPK3—kidney cancer	3.6e-05	0.000532	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.57e-05	0.000528	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CCBL1—kidney cancer	3.5e-05	0.000518	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MYC—kidney cancer	3.5e-05	0.000517	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MYC—kidney cancer	3.5e-05	0.000517	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GPC3—kidney cancer	3.44e-05	0.000508	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MAPK1—kidney cancer	3.42e-05	0.000506	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MAPK1—kidney cancer	3.42e-05	0.000506	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CA2—kidney cancer	3.34e-05	0.000494	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALAD—kidney cancer	3.26e-05	0.000482	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CA9—kidney cancer	3.25e-05	0.000481	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—KRAS—kidney cancer	3.23e-05	0.000478	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KRAS—kidney cancer	3.23e-05	0.000478	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ST3GAL2—kidney cancer	3.18e-05	0.00047	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.18e-05	0.00047	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALDH1A1—kidney cancer	3.11e-05	0.00046	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PPAT—kidney cancer	3.03e-05	0.000449	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.03e-05	0.000449	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.98e-05	0.000441	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PGK1—kidney cancer	2.98e-05	0.000441	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CA—kidney cancer	2.97e-05	0.000439	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CA—kidney cancer	2.97e-05	0.000439	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—LDHB—kidney cancer	2.92e-05	0.000432	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—kidney cancer	2.87e-05	0.000425	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—kidney cancer	2.87e-05	0.000425	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—FH—kidney cancer	2.82e-05	0.000417	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—APRT—kidney cancer	2.82e-05	0.000417	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CRABP1—kidney cancer	2.76e-05	0.000409	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GPC3—kidney cancer	2.65e-05	0.000392	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CA2—kidney cancer	2.58e-05	0.000382	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ITPR2—kidney cancer	2.57e-05	0.00038	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CA9—kidney cancer	2.53e-05	0.000375	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALAD—kidney cancer	2.51e-05	0.000372	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.48e-05	0.000366	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.45e-05	0.000363	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.4e-05	0.000355	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.37e-05	0.00035	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ACHE—kidney cancer	2.34e-05	0.000347	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTT1—kidney cancer	2.34e-05	0.000347	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.3e-05	0.00034	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PGK1—kidney cancer	2.3e-05	0.00034	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—LDHB—kidney cancer	2.26e-05	0.000333	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SCARB1—kidney cancer	2.22e-05	0.000328	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTGS1—kidney cancer	2.2e-05	0.000325	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CRABP1—kidney cancer	2.15e-05	0.000319	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PSMD7—kidney cancer	2.15e-05	0.000319	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—BCHE—kidney cancer	2.04e-05	0.000302	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.02e-05	0.000298	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ITPR2—kidney cancer	2e-05	0.000296	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CA9—kidney cancer	1.96e-05	0.000289	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.95e-05	0.000288	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.89e-05	0.000279	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.85e-05	0.000273	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ACHE—kidney cancer	1.83e-05	0.00027	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTT1—kidney cancer	1.83e-05	0.00027	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SCARB1—kidney cancer	1.73e-05	0.000256	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTGS1—kidney cancer	1.71e-05	0.000253	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PSMD7—kidney cancer	1.68e-05	0.000248	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CRABP1—kidney cancer	1.66e-05	0.000246	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.65e-05	0.000244	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTP1—kidney cancer	1.62e-05	0.00024	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—BCHE—kidney cancer	1.59e-05	0.000235	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.57e-05	0.000232	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ITPR2—kidney cancer	1.55e-05	0.000229	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ABCB1—kidney cancer	1.54e-05	0.000227	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.52e-05	0.000224	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTM1—kidney cancer	1.49e-05	0.000221	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.47e-05	0.000218	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.42e-05	0.000209	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ACHE—kidney cancer	1.41e-05	0.000208	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTT1—kidney cancer	1.41e-05	0.000208	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SCARB1—kidney cancer	1.33e-05	0.000197	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTGS1—kidney cancer	1.32e-05	0.000195	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PSMD7—kidney cancer	1.3e-05	0.000192	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.28e-05	0.00019	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTP1—kidney cancer	1.27e-05	0.000187	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—BCHE—kidney cancer	1.23e-05	0.000182	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.21e-05	0.000179	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCB1—kidney cancer	1.2e-05	0.000177	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.17e-05	0.000173	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTM1—kidney cancer	1.16e-05	0.000172	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.16e-05	0.000172	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.1e-05	0.000163	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—POMC—kidney cancer	1.06e-05	0.000156	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTP1—kidney cancer	9.77e-06	0.000144	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCB1—kidney cancer	9.25e-06	0.000137	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.06e-06	0.000134	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTM1—kidney cancer	8.98e-06	0.000133	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP1A1—kidney cancer	8.51e-06	0.000126	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTGS2—kidney cancer	8.42e-06	0.000124	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—POMC—kidney cancer	8.22e-06	0.000122	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTEN—kidney cancer	7.34e-06	0.000109	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTGS2—kidney cancer	6.56e-06	9.7e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—POMC—kidney cancer	6.35e-06	9.38e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTEN—kidney cancer	5.72e-06	8.46e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CA—kidney cancer	5.18e-06	7.66e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTGS2—kidney cancer	5.06e-06	7.48e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTEN—kidney cancer	4.41e-06	6.53e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CA—kidney cancer	4.04e-06	5.97e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.11e-06	4.61e-05	CbGpPWpGaD
